Effects of Bacillus Coagulans-Based Probiotic on Gut Health and Immune Response in Healthy Adults

This clinical trial is a randomized, double-blind, placebo-controlled study that aims to evaluate the effects of a probiotic product based on Bacillus coagulans on gut health and immune responses in healthy adults. The study seeks to generate evidence on the role of Bacillus coagulans in maintaining gut balance and supporting immune function under normal conditions. The trial is important as it can help understand how probiotics might benefit overall health and well-being in healthy individuals. Participants in this study will be instructed to consume the assigned probiotic or placebo product twice daily, after meals, for the duration of the study. The effects of the probiotic will be assessed through various measures, including changes in fecal calprotectin levels, a well-established biomarker of gut inflammation. Additionally, selected immune and inflammatory markers, such as immunoglobulins, will be evaluated to understand the immunomodulatory effects. Participants will also report their gut health and immune status using validated questionnaires. Safety and tolerability of the probiotic product will be monitored throughout the study.